Minorities, Women Underrepresented in Pancreatic Cancer Trials
84.7 percent of patients in clinical trials were White and 54.8 percent were men; underrepresentation seen in trials of nearly all phases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.